Pharmacokinetics Study of the Long-acting Antiarrhythmic Drug of Lappaconitine Hydrobromide (Allaforte®, JSC "Pharmcenter VILAR", Russia)

Pharmacokinetics Study of the Long-acting Antiarrhythmic Drug of Lappaconitine Hydrobromide (Allaforte®, JSC "Pharmcenter VILAR", Russia)

Introduction. Allaforte® (JSC "Pharmcenter VILAR", Russia) is an antiarrhythmic long-acting drug. The dosage form of the drug Allaforte® provides a decrease in the frequency of taking the drug and also reduces the risk of side effects. It is relevant when taking antiarrhythmic drugs of the...

Full description

Saved in:
Bibliographic Details
Main Authors: O. A. Archakova, N. S. Bagaeva, T. N. Komarov, A. V. Rogov, D. S. Shchelgacheva, A. V. Suvorova, P. K. Karnakova, P. A. Karpova, I. E. Shohin
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2022-02-01
Series:Разработка и регистрация лекарственных средств
Subjects:
lappaconitine
n-desacetyllappaconitine
allaforte®
plasma
pharmacokinetics
arrhythmya
Online Access:https://www.pharmjournal.ru/jour/article/view/1172
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.pharmjournal.ru/jour/article/view/1172

Similar Items